Endurance RP Limited (0575.HK)

HKD 0.37

(12.12%)

Market Cap (In HKD)

84.52 Million

Revenue (In HKD)

382 Thousand

Net Income (In HKD)

-25.04 Million

Avg. Volume

16.77 Thousand

Currency
HKD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
0.32-0.7
PE
-
EPS
-
Beta Value
1.044
ISIN
KYG3042R1314
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Asset Management
CEO
Mr. Jamie Alexander Gibson
Employee Count
-
Website
https://www.endurancerp.com
Ipo Date
1997-05-19
Details
Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.